Human Factor IX (Factor 9) AssayMax ELISA Kit | Assaypro

Human Factor IX (Factor 9) AssayMax ELISA Kit


DETAILS
Description:	This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Type:	AssayMax ™ ELISA Kits
Samples:	Serum Plasma Cell Culture Supernatant CSF
Catalog Number:	EF1009-1
Species:	Human
Format:	Sandwich ELISA
Size:	96 Well Plate
Range:	1.56 - 100 ng/ml; 0.313 - 20 mIU/ml
Research Area:	Blood Disorder
Entrez Gene:	2158
UniProt:	P00740
Synonyms:	Coagulation Factor 9, Coagulation Factor IX, Factor IX, Christmas Disease Factor, Christmas Factor, F9, FIX, Haemophilia B Factor, HEMB, MGC129641, MGC129642, P19, Plasma Thromboplastic Component, PTC , factor ix, factor 9, factor 9 elisa, factor ix elisa
Note:	For Research Use Only, Not To Be Used For Diagnostic Purposes


Product References:	* Than PA et al. (2022) Selective Microvascular Tissue Transfection Using Minicircle DNA for Systemic Delivery of Human Coagulation Factor IX in a Rat Model Using a Therapeutic Flap. Plast Reconstr Surg. 149(1):117-129 * Kruse RL (2021) Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liver. Gastrointest Endosc. S0016-5107(21)01463-2. * Engelmann B (2018) Plasma Proteome Analyses of Experimental Human and Murine Thyroid Disease Models. Ernst Moritz Arndt University of Greifswald. Dessertation. * Ramaswamya S et al. (2017) Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proc Natl Acad Sci USA. 114(10):E1941-E1950. * DeRosa F et al. (2016) Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system. Gene Therapy 23:699- * Heartlein M et al. (2015) Lipid formulations for delivery of messenger rna. Patents: US 20150140070 A1. * Maher SP (2014) Development of an efficient human hepatocyte culture platform for assessing novel therapeutic efficacy against Plasmodium liver parasites. University of South Florida. Graduate Theses and Dissertations. * Heartlein M (2014) Mrna therapeutic compositions and use to treat diseases and disorders. Patent application:WO2014152940 A1 * Derosa F et al.(2014) Lipidic nanoparticles for mrna delivering. Patent application:WO2014089486 A1 * Ostroff RM et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One. 7(10):e46091 * Guild BC et al. (2012) Lipid nanoparticle compositions and methods for mrna delivery. Patent Application WO2012170930 A1 * Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 * Dadehbeigi N et al. (2008) Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines. Biotechnol Lett. 30(11):1909-12


ORDERING
Price:	$360
Add to Cart:
Data Sheet:
MSDS/SDS:
Image:
Related Products:	Human Factor IX (Factor 9) Antibody Human Factor IX (Factor 9) Antibody (Biotin Conjugate) Human Factor IX (Factor 9) AssayLite Antibody (FITC Conjugate) Human Factor IX (Factor 9) AssayLite Antibody (RPE Conjugate) Human Factor IX (Factor 9) AssayLite Antibody (APC Conjugate) Human Factor IX (Factor 9) AssayLite Antibody (PerCP Conjugate) Human Factor IXa Antibody Human Factor IXa Antibody (Biotin Conjugate) Human Factor IXa AssayLite Antibody (FITC Conjugate) Human Factor IXa AssayLite Antibody (RPE Conjugate) Human Factor IXa AssayLite Antibody (APC Conjugate) Human Factor IXa AssayLite Antibody (PerCP Conjugate) Human Factor IX (Factor 9) Antibody Human Factor IX (Factor 9) Antibody (Biotin Conjugate) Human Factor IX (Factor 9) AssayLite Antibody (FITC Conjugate) Human Factor IX (Factor 9) Antibody Human Factor IX (Factor 9) Antibody (Biotin Conjugate) Human Factor IX (Factor 9) AssayLite Antibody (FITC Conjugate) Human Factor IX (Factor 9) Monoclonal Antibody Human Factor IX (Factor 9) Monoclonal Antibody (Biotin Conjugate) Human Factor IX (Factor 9) Monoclonal AssayLite Antibody (FITC Conjugate) Human Factor IX AssayMax ELISA Kit Positive Reference Plasma Control (Calibrated against WHO Standard) Human Factor IX AssayMax ELISA Kit Low (Negative) Reference Control Human Factor IX (Factor 9) Deficient Plasma (Sodium Citrate) Human Factor IX (Factor 9) Deficient Plasma (EDTA) Human Factor IX (Factor 9) Deficient Plasma (Heparin) Human Factor IX (Factor 9) Deficient Serum Human Factor IX (Factor 9) AssayMax ELISA Kit (WHO Standard Calibrated Positive Control Included) Human Factor IX (Factor 9) AssayMax ELISA Kit (WHO Standard Calibrated Positive and Low Controls Included) Human Factor IX (Factor 9) Human Factor IXa Beta